Let's Talk ID

With schools set to re-open, the number of children COVID-19 hospitalizations on the rise, and vaccinations not yet authorized for children under age 12, what is the most important thing you can do to protect yourself and others? Dr. Preeti Malani, of the University of Michigan, and Dr. Tina Tan, of Northwestern University, weigh in on back-to-school and vaccination policies.

COVID-19: the race between the variants and the vaccinations. Do desperate times call for desperate measures? HIVMA Chair Rajesh Gandhi, MD, with Harvard University, and 2020 IDSA Society Citation Awardee Adarsh Bhimraj, MD, with the Cleveland Clinic, discuss COVID-19 treatments: the knowns, unknowns, and important factors in stemming the future of the pandemic.

Vaccination rates are inconsistent around the U.S. and globally. Is it safe to travel for summer vacations? Trish Perl, MD, FIDSA, of the University of Texas Southwestern Medical Center, and Preeti Malani, MD, FIDSA, of the University of Michigan, join us to discuss summer vacationing, travel, and how to be safe.

Is the “Fauci effect” enough to attract the number of doctors needed into the field of ID? In this episode, IDSA President Barbara Alexander, MD, FIDSA is joined by Wendy Armstrong, MD, FIDSA, of Emory University School of Medicine, and Michael Melia, MD, FIDSA, of Johns Hopkins School of Medicine, to discuss the current state of the ID Match and IDSA’s efforts to address recruitment into the field as well as its mentorship and professional development efforts.

In this episode, produced in partnership with the Mycoses Study Group Education and Research Consortium (MSGERC), we discuss Mucormycosis: the deadly fungal infection affecting COVID-19 patients in India with IDSA and MSGERC members, Ilan Schwartz, MD, PhD, Assistant Professor in the Division of Infectious Diseases at the University of Alberta, and Andrej Spec, MD, MS, Associate Director of the Infectious Diseases Clinical Research Unit, Director of the Invasive Mycoses Clinic, and Assistant Professor of Medicine in the Division of Infectious Diseases at Washington University School of Medicine in St. Louis.

The Infectious Diseases Society of America's Guideline Podcast provides concise summaries of the most important IDSA guidelines. For the full version of the guidelines presented, please go to www.idsociety.org. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health Stuart Johnson, M.D., Professor of Medicine, Loyola University Medical Center; Clinician Researcher, Departments of Research and Medicine, Edward Hines Jr. Veterans Administration Hospital

IDSA Board members Dr. Angela Caliendo, MD, PhD, FIDSA, Professor and Executive Vice Chair of Medicine at Alpert Medical School of Brown University, and Dr. Kimberly Hanson, MD, Professor at the University of Utah School of Medicine discuss Antigen Testing: What it is, what role testing will play from a screening perspective, and testing effectiveness.

In this episode, we discuss the CDC’s new masking guidance, the recommendations, surrounding challenges, and a return to the abnormal with IDSA Board Member and Fellow Dr. Jeanne Marrazzo, Professor of Medicine and Director of the Division of Infectious Diseases at the University of Alabama at Birmingham, and Dr. Joshua Barocas, member of IDSA’s Public Health Committee and Assistant Professor of Medicine at the Boston University School of Medicine and Infectious Diseases physician at Boston Medical Center.

IDSA members Krutika Kuppali, MD, of the Medical University of South Carolina, and Dawd Siraj, MD, of the University of Wisconsin-Madison, discuss the rapid rise in COVID-19 cases in India and whether the African continent will face a similar wave soon.

IDSA members Susan Kline, MD, of the University of Minnesota, Monica Gandhi, MD, of UC-San Francisco, and Jason Newland, MD, of Washington University, share thoughts about gatherings, mask protocol, and the trajectory of COVID-19 over the summer.